Variant position: 494 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 676 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human LKLDNVLLDRDGHIKIADFG MCKENIFGESRASTFCGTPDY
Mouse LKLDNVMLDRDGHIKIADFG MCKENIFGEGRASTFCGTPDY
Rat LKLDNVMLDKDGHIKIADFG MCKENIFGENRASTFCGTPDY
Dog LKLDNVMLDQDGHIKIADFG MCKENIFGEKQASTFCGTPDY
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
1 – 676 Protein kinase C delta type
330 – 676 Protein kinase C delta type catalytic subunit
349 – 603 Protein kinase
503 – 503 Phosphoserine
506 – 506 Phosphoserine
507 – 507 Phosphothreonine; by autocatalysis
507 – 507 T -> A. No effect on kinase activity.
Identification of multiple, novel, protein kinase C-related gene products.
Palmer R.H.; Ridden J.; Parker P.J.;
FEBS Lett. 356:5-8(1994)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 432-533 (ISOFORM 1); VARIANT VAL-494;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.